Overview
Dental Nanotechnology is a company that specializes in dental products and tools for endodontic treatment, particularly focusing on preventing secondary infections during root canal procedures. They offer specialized dental materials, such as NANOCARE PLUS, designed to eliminate the risk of post-treatment infections. Additionally, they provide various disinfecting agents used in root canal therapy, available through dental wholesalers.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2011-06-03. Active
66 1910 1048 2501 0373 0782 0001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
21 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| May 11, 2026 | Shareholders' meeting convened | |
| Jun 2, 2025 | Shareholders' meeting convened | |
| Jun 6, 2024 | Shareholders' meeting convened | |
| May 31, 2023 | Shareholders' meeting convened | |
| Aug 16, 2022 | Shareholders' meeting convened |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 8, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $9,847$9,847 | Polski Fundusz Rozwoju S.A. | |
| May 8, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Katowice |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy are authorised to make declarations on behalf of the company, except for incurring liabilities whose value does not exceed PLN 50,000.00 (fifty thousand zloty), for which each member of the management board is authorised to act independently.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Tadeusz Jacek Borczyk (61)  | Shareholder of a joint-stock company, 0.7125% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| BENA Sipcosp. z o.o. | $156,087.94 | bena-med.pl | ||
| Neomedixsp. z o.o. | $126,859.17 | neomedix.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-11-10 | PKD change (Removed: 18.1, 18.2, 21.1, 38.1, 38.2, 38.3, 39.0, 46.1, 46.46.Z, 46.6, 46.7, 46.76.Z, 46.9, 47.73.Z, 58.1, 58.2, 64.99.Z, 68.1, 68.2, 68.3, 71.2, 72.19.Z, 81.29.Z, 82.9, 85.59.B, 86.9; Added: 33.13.Z, 33.14.Z, 33.19.Z) | |
| 2011-11-04 | Share capital change (100,000.00 PLN → 4,000,000.00 PLN) | |
| 2011-05-10 | Entered in the register |
FAQ
Last updated: 2026-06-11